WallStreetZenWallStreetZen

NASDAQ: CTMX
Cytomx Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cytomx Therapeutics earnings were $41.6M for the trailing 12 months ending Mar 31, 2025, with 145% growth year over year. The latest CTMX earnings report on Mar 31, 2025 announced Q1 2025 earnings of $23.5M, up 24.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CTMX reported annual earnings of $31.9M, with -5,700.9% growth.

CTMX past earnings growth

How has CTMX's earnings growth performed historically?

Company
145%
Industry
11.53%
Market
34%
CTMX's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CTMX's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CTMX's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CTMX earnings history

Current Revenue
$147.6M
Current Earnings
$41.6M
Current Profit Margin
28.2%

CTMX Return on Equity

Current Company
-553.1%
Current Industry
-60.2%
Current Market
31.5%
CTMX's Return on Equity (-553.1%)... subscribe to Premium to read more.
High Return on Equity Performance

CTMX undefined

Current Company
32.2%
Current Industry
-2.5%
CTMX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CTMX announces earnings.

CTMX undefined

Current Company
86.63%
Current Industry
5.8%
CTMX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CTMX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CTMX$47.70M$41.60M+145.00%$0.49
MDWD-$18.84M-$21.22MN/A-$2.04
FENC-$11.14M-$14.44MN/A-$0.53
TIL-$66.49M-$78.03MN/A-$11.97
DSGN-$55.59M-$56.20MN/A-$0.99
View Top Biotech Stocks

Cytomx Therapeutics Earnings Reports & History FAQ

What were Cytomx Therapeutics's earnings last quarter?

On CTMX's earnings call on Invalid Date, Cytomx Therapeutics (NASDAQ: CTMX) reported Q1 2025 earnings per share (EPS) of $0.27, up 58.82% year over year. Total CTMX earnings for the quarter were $23.53 million. In the same quarter last year, Cytomx Therapeutics's earnings per share (EPS) was $0.17.

If you're new to stock investing, here's how to buy Cytomx Therapeutics stock.

Is Cytomx Therapeutics profitable or losing money?

As of the last Cytomx Therapeutics earnings report, Cytomx Therapeutics is currently profitable. Cytomx Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $41.60 million, a 151.64% increase year over year.

What was CTMX's earnings growth in the past year?

As of Cytomx Therapeutics's earnings date in Invalid Date, Cytomx Therapeutics's earnings has grown 145% year over year. This is 133.47 percentage points higher than the US Biotechnology industry earnings growth rate of 11.53%. CTMX earnings in the past year totalled $41.60 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.